Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus exenatide before pregnancy in overweight or obese women with infertility due to polycystic ovary syndrome
ChiCTR2100041813Phase 4Completed
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Jan 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin and exenatide in polycystic ovary syndrome (PCOS) and female infertility (2 arms), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoint: spontaneous pregnancy rate. Started Jan 2019; status: completed.
02
Drugs
metforminexenatide
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on ChiCTR2100041813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041813.